Osteoarthritis (OA), the most common form of arthritis, is a degenerative joint disease, whose complex and multifactorial aetiology bridges biomechanics and biochemistry.
Normal articular cartilage has a unique load support mechanism governed by collagen–proteoglycan matrix, with its high water content, stiffness and permeability.
Because of low bioavailability and chain length specific effect of hyaluronan, ROELMI HPC has developed the Full Spectrum Technology based on a fine modulation of the biofermentation production process, to obtain a wider spectrum of hyaluronan molecular weights called HA Tech 2.0®.
Such approach through an orally administrable and effective Full Spectrum-HA allows a better compliance for patients, representing a cost-saving and less invasive solution for knee OA treatment if compared to injectable treatments.